Literature DB >> 2005922

Writer's cramp: treatment with botulinum toxin injections.

J Rivest1, A J Lees, C D Marsden.   

Abstract

Twelve patients with writer's cramp were treated with injections of botulinum toxin. The overactive muscles were identified by clinical observation of the subjects while they were writing. Repeated injections were given at 2-week intervals until the optimal response was obtained. Eleven patients reported some benefit, which was considered by seven to be significant. Eight of the 10 patients who had pain reported moderate to significant relief. Five patients had local complications, consisting of disabling weakness of target or neighbouring muscles. These preliminary results suggest that this treatment can be successfully applied to many patients with writer's cramp without performing complex electromyographic recordings while the patients are writing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005922     DOI: 10.1002/mds.870060110

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Botulinum toxin.

Authors:  A J Lees
Journal:  BMJ       Date:  1992-11-14

Review 2.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

3.  Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.

Authors:  J J M Kruisdijk; J H T M Koelman; B W Ongerboer de Visser; R J de Haan; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-21       Impact factor: 10.154

Review 4.  Evidence for the effectiveness of botulinum toxin for writer's cramp.

Authors:  K Dashtipour; R A Pender
Journal:  J Neural Transm (Vienna)       Date:  2008-03-06       Impact factor: 3.575

5.  Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.

Authors:  J Wissel; C Kabus; R Wenzel; S Klepsch; U Schwarz; A Nebe; L Schelosky; U Scholz; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

6.  Isolated idiopathic adult-onset foot dystonia and treatment with botulinum toxin.

Authors:  J Duarte; A P Sempere; F Coria; L E Clavería; F A Frech; A L Mataix; E Martinez
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

Review 7.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

8.  Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.

Authors:  A J Lees; N Turjanski; J Rivest; R Whurr; M Lorch; G Brookes
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

9.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

10.  Local botulinum toxin in the treatment of spastic drop foot.

Authors:  R Dengler; U Neyer; K Wohlfarth; U Bettig; H H Janzik
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.